Enhancement of antimycotic activity of amphotericin B by targeting the oxidative stress response of Candida and Cryptococcus with natural dihydroxybenzaldehydes

Frontiers in Microbiology

Volumn 3, Issue JUL, 2012, Pages

  Kim, Jong H ^a   Faria, Natália C G ^b   Martins, M De L ^b   Chan, Kathleen L ^a   Campbell, Bruce C ^a  

^a WESTERN REGIONAL RESEARCH CENTER   (United States)

^b INSTITUTO DE HIGIENE E MEDICINA TROPICAL   (Portugal)

Author keywords

Amphotericin B; Antioxidant system; Candida; Chemosensitization; Cryptococcus; Dihydroxybenzaldehydes; Superoxide dismutase

Indexed keywords

EID: 84875801870     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2012.00261     Document Type: Article

References (25)

1. Allen, U. (2010). Antifungal agents for the treatment of systemic fungal infections in children. Paediatr. Child Health 15, 603-615.
2. An, M., Shen, H., Cao, Y., Zhang, J., Cai, Y., Wang, R., and Jiang, Y. (2009). Allicin enhances the oxidative damage effect of amphotericin B against Candida albicans. Int. J. Antimicrob. Agents 33, 258-263.
3. Arendrup, M. C., Cuenca-Estrella, M., Lass-Flörl, C., Hope, W., (2012) The EUCAST-AFST. EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2. Clin. Microbiol. Infect. 18, E246-E247.
4. Beggs, W. H., Andrews, F. A., and Sarosi, G. A. (1978). Synergistic action of amphotericin B and antioxidants against certain opportunistic yeast pathogens. Antimicrob. Agents Chemother. 13, 266-270.
5. Bink, A., Vandenbosch, D., Coenye, T., Nelis, H., Cammue, B. P., and Thevissen, K. (2011). Superoxide dismutases are involved in Candida albicans biofilm persistence against miconazole. Antimicrob. Agents Chemother. 55, 4033-4037.
6. Blum, G., Perkhofer, S., Haas, H., Schrettl, M., Würzner, R., Dierich, M. P., and Lass-Flörl, C. (2008). Potential basis for amphotericin B resistance in Aspergillus terreus. Antimicrob. Agents Chemother. 52, 1553-1555.
7. Clemons, K. V., Schwartz, J. A., and Stevens, D. A. (2011). Therapeutic and toxicologic studies in a murine model of invasive pulmonary aspergillosis. Med. Mycol. 49, 834-847.
8. de Dios, C. H., Román, E., Monge, R. A., and Pla, J. (2010). The role of MAPK signal transduction pathways in the response to oxidative stress in the fungal pathogen Candida albicans: implications in virulence. Curr. Protein Pept. Sci. 11, 693-703.
9. Fernandes, L., Rodrigues-Pousada, C., and Struhl, K. (1997). Yap, a novel family of eight bZIP proteins in Saccharomyces cerevisiae with distinct biological functions. Mol. Cell. Biol. 17, 6982-6993.
10. González-Párraga, P., Sánchez-Fresneda, R., Zaragoza, O., and Argüelles, J. C. (2011). Amphotericin B induces trehalose synthesis and simultaneously activates an antioxidant enzymatic response in Candida albicans. Biochim. Biophys. Acta 1810, 777-783.
11. Graybill, J. R., Burgess, D. S., and Hardin, T. C. (1997). Key issues concerning fungistatic versus fungicidal drugs. Eur. J. Clin. Microbiol. Infect. Dis. 16, 42-50.
12. Hamilton, A. J., and Holdom, M. D. (1999). Antioxidant systems in the pathogenic fungi of man and their role in virulence. Med. Mycol. 37, 375-389.
13. Jacob, C. (2006). A scent of therapy: pharmacological implications of natural products containing redox-active sulfur atoms. Nat. Prod. Rep. 23, 851-863.
14. Kim,J. H.,Chan,K. L.,Mahoney,N.,and Campbell, B. C. (2011). Antifungal activity of redox-active benzaldehydes that target cellular antioxidation. Ann. Clin. Microbiol. Antimicrob. 10, 23.
15. Kim, J. H., Mahoney, N., Chan, K. L., Molyneux, R. J., May, G. S., and Campbell, B. C. (2008). Chemosensitization of fungal pathogens to antimicrobial agents using benzo analogs. FEMS Microbiol. Lett. 281, 64-72.
16. Kirkman, T. W. (1996). Statistics to Use. Available at: www.physics.csbsju.edu/stats/ [accessed May 22, 2012]
17. Lee, J., Godon, C., Lagniel, G., Spector, D., Garin, J., Labarre, J., and Toledano, M. B. (1999). Yap1 and Skn7 control two specialized oxidative stress response regulons in yeast. J. Biol. Chem. 274, 16040-16046.
18. Odds, F. (2003). Synergy, antagonism, and what the chequerboard puts between them. J. Antimicrob. Chemother. 52, 1.
19. Okamoto, Y., Aoki, S., and Mataga, I. (2004). Enhancement of amphotericin B activity against Candida albicans by superoxide radical. Mycopathologia 158, 9-15.
20. Palacios, D. S., Anderson, T. M., and Burker, M. D. (2007). A postPKS oxidation of the amphotericin B skeleton predicted to be critical for the channel formation is not required for potent antifungal activity. J. Am. Chem. Soc. 129, 13804-13805.
21. Patel,G. P.,Crank,C.W.,and Leikin,J. B. (2011). An evaluation of hepatotoxicity and nephrotoxicity of liposomal amphotericin B (L-AMB). J. Med. Toxicol. 7, 12-15.
22. Sokol-Anderson, M. L., Brajtburg, J., and Medoff, G. (1986). Amphotericin B-induced oxidative damage and killing of Candida albicans. J. Infect. Dis. 154, 76-83.
23. Walsh, T. J., Petraitis, V., Petraitiene, R., Field-Ridley, A., Sutton, D., Ghannoum, M., Sein, T., Schaufele, R., Peter, J., Bacher, J., Casler, H., Armstrong, D., Espinel-Ingroff, A., Rinaldi, M. G., and Lyman, C. A. (2003). Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B. J. Infect. Dis. 188, 305-319.
24. Washburn, R. G., Gallin, J. I., and Bennett, J. E. (1987). Oxidative killing of Aspergillus fumigatus proceeds by parallel myeloperoxidase-dependent and -independent pathways. Infect. Immun. 55, 2088-2092.
25. Wong, S. Y. Y., Grant, I. R., Friedman, M., Elliot, C. T., and Situ, C. (2008). Antibacterial activities of naturally occurring compounds against Mycobacterium avium subsp. paratuberculosis. Appl. Environ. Microbiol. 74, 5986-5990.